Table 7.
Number of prozone positive samples for additional HRP-2 RDT brands that were assessed with samples positive for prozone with at least one of the RDTs from Table 3
| Brands/Manufacturers | P. falciparum antigen target | Number of samples tested | Total number of samples with prozone (%) | HRP-2 or Pf-pLDH line intensity for undiluted prozone positive samples | ||
|---|---|---|---|---|---|---|
| Negative | Faint | Weak | ||||
| Hexagon Malaria | HRP-2 | 39 | 13 (33.3%) | - | 0 | 13 |
| Malaria Total Quick | HRP-2 | 44 | 22 (50.0%) | - | 5 | 17 |
| First Response Malaria Ag Combo | HRP-2 | 40 | 34 (85.0%) | - | 7 | 27 |
| ICT Malaria Combo | HRP-2 | 34 | 7 (20.6%) | - | 1 | 6 |
| Malaria Pan/Pv/Pf Rapid‡ Device | HRP-2 | 43 | 22 (51.2%) | - | 4 | 18 |